Featured

Lyphe is proud to introduce the Noidecs V Range, a new line of medical cannabis products that simplifies treatment options for patients while addressing the biggest challenges in the UK …

Germany has taken a groundbreaking step in cannabis reform with the launch of its cannabis pilot programme under the Cannabis Control Act (CanG). This initiative, which integrates research, regulation, and …

Kamala Harris’ endorsement of cannabis legalisation, made during an appearance on All The Smoke, represents a pivotal shift in her campaign and positions her as one of the key figures …

Recent research by Lindsey Metcalf McGrath and Helen Beckett Wilson shines a light on the lived experiences of UK cannabis patients, revealing a stark disconnect between legal prescriptions and the …

The recent increase in ketamine use among young people, highlighted in The Guardian by Owen Bowden-Jones, has ignited concerns across the UK. While some experts, including Bowden-Jones, have described this …

Welcome to August’s analysis of the MedBud traffic data. The most interesting month we have had yet, and a clear sign that the data we analyse provides a real time …

The UK government’s decision to ban xylazine, while aimed at addressing public health concerns, has been accompanied by deeply troubling rhetoric, labelling the substance as a “zombie drug.” This kind …

As the use of prescription cannabis becomes increasingly common in the UK, landlords and housing associations are facing a new legal challenge: how to accommodate tenants who use medical cannabis. …

Former President Donald Trump’s recent support for the legalisation of adult-use cannabis in Florida, via Amendment 3, marks a significant shift in both his political strategy and the Republican Party’s …

Labour’s recent proposal to ban disposable vapes, citing concerns over youth access and environmental impact, is a significant misstep. While these issues warrant attention, an outright ban ignores the crucial …